Pay in 4 interest-free payments of $6.38 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Betsy A, Binitha M, Sarita S
Both capsule and powder forms meet this purity standard
The diseases that need network pharmacology most are getting it last and we need to close that gap
Benefits & Results
Absence of expected improvement by mid-protocol (4-6 weeks) warrants reassessment
Primary APP23 mouse neurons were infected with lentivirus carrying scramble sequence or short-hairpin RNA (shRNA) sequence targeting AMPK, with or without treatment of exendin-4
US$ 21.96
US$ 23.03
US$ 20.45
US$ 29.88
